Literature DB >> 7531702

Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product.

M Tewari1, V M Dixit.   

Abstract

crmA is a cowpox virus gene that encodes a protease inhibitor of the serpin family. The only reported target for the CrmA protein is the cysteine protease interleukin-1 beta converting enzyme (ICE). ICE, by virtue of its homology to the Caenorhabditis elegans cell death protein Ced-3, has been suggested to play a fundamentally important role in mammalian apoptosis. We hypothesized that a function of crmA may be to inhibit cell death, since a major mechanism of viral clearance is the immune system-mediated induction of apoptosis of infected cells. The tumor necrosis factor receptor and the Fas antigen are two cytokine receptors which, by engaging and activating the death pathway, can eliminate virus-infected cells. Remarkably, crmA was found to be an exceptionally potent inhibitor of apoptosis induced by both these receptors, capable of blocking the cell death program even at pharmacological doses of the death stimulus. Therefore, an important new function for crmA is the inhibition of cytokine-induced apoptosis. Further, the data suggest that a protease, either ICE or a related crmA-inhibitable protein, is a component of the Fas- and tumor necrosis factor-induced cell death pathways.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7531702     DOI: 10.1074/jbc.270.7.3255

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  134 in total

1.  Inhibition of mitogen-activated kinase signaling sensitizes HeLa cells to Fas receptor-mediated apoptosis.

Authors:  T H Holmström; S E Tran; V L Johnson; N G Ahn; S C Chow; J E Eriksson
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  Apoptosis: A Current Molecular Analysis.

Authors:  Dean G Tang; Arthur T Porter
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

3.  Role for caspase-mediated cleavage of Rad51 in induction of apoptosis by DNA damage.

Authors:  Y Huang; S Nakada; T Ishiko; T Utsugisawa; R Datta; S Kharbanda; K Yoshida; R V Talanian; R Weichselbaum; D Kufe; Z M Yuan
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

4.  Subcellular localization of CrmA: identification of a novel leucine-rich nuclear export signal conserved in anti-apoptotic serpins.

Authors:  Jose A Rodriguez; Simone W Span; Frank A E Kruyt; Giuseppe Giaccone
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

5.  Interictal spikes in developing rats cause long-standing cognitive deficits.

Authors:  Omar I Khan; Qian Zhao; Forrest Miller; Gregory L Holmes
Journal:  Neurobiol Dis       Date:  2010-05-07       Impact factor: 5.996

Review 6.  Poxvirus immunomodulatory strategies: current perspectives.

Authors:  J B Johnston; Grant McFadden
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

7.  Two newly characterized germinal center B-cell-associated genes, GCET1 and GCET2, have differential expression in normal and neoplastic B cells.

Authors:  Zenggang Pan; Yulei Shen; Cheng Du; Guimei Zhou; Andreas Rosenwald; Louis M Staudt; Timothy C Greiner; Timothy W McKeithan; Wing C Chan
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

Review 8.  DNA-stimulated cell death: implications for host defence, inflammatory diseases and cancer.

Authors:  Søren R Paludan; Line S Reinert; Veit Hornung
Journal:  Nat Rev Immunol       Date:  2019-03       Impact factor: 53.106

9.  NF-kappaB protects from the lysosomal pathway of cell death.

Authors:  Ni Liu; Srikumar M Raja; Francesca Zazzeroni; Sunil S Metkar; Ramila Shah; Manling Zhang; Yue Wang; Dieter Brömme; William A Russin; Justine C Lee; Marcus E Peter; Christopher J Froelich; Guido Franzoso; Philip G Ashton-Rickardt
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

10.  Evaluation of novel antimouse VEGFR2 antibodies as potential antiangiogenic or vascular targeting agents for tumor therapy.

Authors:  Sophia Ran; Xianming Huang; Amber Downes; Philip E Thorpe
Journal:  Neoplasia       Date:  2003 Jul-Aug       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.